Header Logo

Connection

Nomathemba Chandiwana to Anti-Retroviral Agents

This is a "connection" page, showing publications Nomathemba Chandiwana has written about Anti-Retroviral Agents.
Connection Strength

0,493
  1. Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):e478-e487.
    View in: PubMed
    Score: 0,163
  2. Stillbirth rate by maternal HIV serostatus and antiretroviral use in pregnancy in South Africa: An audit. S Afr Med J. 2021 09 02; 111(9):822-823.
    View in: PubMed
    Score: 0,138
  3. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 08 29; 381(9):803-815.
    View in: PubMed
    Score: 0,119
  4. Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries. AIDS. 2023 05 01; 37(6):1009-1011.
    View in: PubMed
    Score: 0,038
  5. Weight gain stopping/switch rules for antiretroviral clinical trials. AIDS. 2021 12 15; 35(Suppl 2):S183-S188.
    View in: PubMed
    Score: 0,035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.